Evaluation of the INNOVANCE PFA P2Y test cartridge: Sensitivity to P2Y12blockade and influence of anticoagulant

A case-control study on platelet reactivity in patients with coronary stent thrombosis

(2011) H. J. BOUMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Assessment of clopidogrel non-response by the PFA-100® system using the new test cartridge INNOVANCE® PFA P2Y

(2010) Birgit Linnemann et al.   ANNALS OF HEMATOLOGY

Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies

(2010) Paul A. Gurbel et al.   CIRCULATION

Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation

(2010) Nicoline J. Breet   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

(2010) Laurent Bonello et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The new INNOVANCE® PFA P2Y cartridge is sensitive to the detection of the P2Y12receptor inhibition

(2010) Juergen Koessler et al.   PLATELETS

Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function

(2010) Robert Buckland et al.   THROMBOSIS AND HAEMOSTASIS

The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo

(2010) Florian B. Mayr et al.   TRANSFUSION

Novel Antiplatelet Agents in Development: Prasugrel, Ticagrelor, and Cangrelor and Beyond

(2009) Inna Shalito et al.   AMERICAN JOURNAL OF THERAPEUTICS

Comparison between hirudin and citrate in monitoring the inhibitory effects of P2Y12 receptor antagonists with different platelet function tests

(2009) C. A. C. M. PITTENS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

The effect of ex vivo anticoagulants on whole blood platelet aggregation

(2009) Madeleine L. Kalb et al.   PLATELETS

The aptamer ARC1779 is a potent and specific inhibitor of von willebrand factor mediatedex vivoplatelet function in acute myocardial infarction

(2009) Alexander O. Spiel et al.   PLATELETS

P2Y 12 Antagonism

(2008) Alan D. Michelson   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Assessing the Current Role of Platelet Function Testing

(2008) Eugene Braunwald et al.   CLINICAL CARDIOLOGY

Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo

(2008) David Erlinge et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities

(2008) A. L. FRELINGER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The importance of anticoagulant agents in measuring platelet aggregation in patients treated with clopidogrel and aspirin

(2008) H. J. BOUMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS